Inspiring Change Conference Glyn Walduck, NPA

Inspiring Change
Leading Innovation to challenge the past and deliver
quality outcomes for the future
Supported by:
Creating Innovation in Community Pharmacy
Medication Safety – An NPA Case Study
Glyn Walduck
Head of Claims
NPA Insurance Ltd
Creating Innovation in Community Pharmacy
Medication Safety Officer
Patient Safety Quarterly Report – Quarter 1 (January –
March) 2017
www.npa.co.uk/news-and-events/news-item/latestpatient-safety-quarterly-report-meet-quality-criteria/
Creating Innovation in Community Pharmacy
Wrong Drug – Selection errors
Prednisolone and Gliclazide
Methotrexate – lessons learned?
Creating Innovation in Community Pharmacy
Right Drug – Wrong Strength
Dexamethasone
PMR s - use them, but with caution, to maintain patient
wellbeing!
Creating Innovation in Community Pharmacy
Right Patient – Right Drug
The name game!
Allcote/Aucote
How to “address” these concerns
Creating Innovation in Community Pharmacy
Script – misinterpretation
Trimethoprim 50mg/5ml “take four 5ml spoonfuls twice a
day”
Labelled as “take four 20ml spoonfuls twice a day”
Going solo? Take a break – rectify that mistake!
Creating Innovation in Community Pharmacy
Transposition of Dispensed Medicines in pharmacy
Trimethoprim 50mg/5ml oral suspension “10ml
twice daily” – 60ml prescribed
Methadone 1mg/1ml oral solution 60ml dispensed
Separate the function at the junction!